CMS CMS Releases Latest Outlook for Future Drug Spending Thomas Sullivan May 29, 2020 0 Recently, the Centers for Medicare and Medicaid Services (CMS) released their projections for the United States National Health…
COVID-19 FDA User-Fee Reviews Continue through COVID-19 Thomas Sullivan May 28, 2020 0 While many facets of our lives have been put on hold due to COVID-19, the United States Food and Drug Administration (FDA) has…
Pharmaceutical and Device Consumers’ Impression of Pharma Is More Favorable Now Thomas Sullivan May 27, 2020 0 We have long heard about the negative impression Americans had of the pharmaceutical industry. However, a recent Harris Poll may…
Medical Legal California Risperdal Suits to be Renewed? Thomas Sullivan May 26, 2020 0 On May 8, 2020, the Second District Court of Appeal in California issued a decision that may reinstate potentially hundreds of…
COVID-19 FDA CDRH Issues Guidance on Notifications of Medical Device Shortages Thomas Sullivan May 22, 2020 0 Recently, the US Food and Drug Administration (“FDA”) Center for Devices and Radiological Health (“CDRH”) published guidance…
CMS HHS Quietly Outlaws Surprise Medical Billing for Everyone? Thomas Sullivan May 21, 2020 0 Federal officials said if hospitals and other providers take emergency funds amid the COVID-19 pandemic, they will be barred from…
Anti Kickback HHS Issues Blanket Waivers for Stark Law – Physician Self-Referral in… Thomas Sullivan May 20, 2020 0 The US Department of Health and Human Services (“HHS”) recently announced that it will issue blanket waivers of the Stark Law for…
COVID-19 Decrease in Routine Medical Care for Hospitals Leads to Furloughs and Pay… Thomas Sullivan May 19, 2020 0 While news reports of overwhelmed and exhausted front-line healthcare workers have been getting a lot of attention in the media,…
CMS CMS Add COVID-19 Clinical Trial Participation Improvement Activity to MIPS… Thomas Sullivan May 18, 2020 0 Recently, the Centers for Medicare & Medicaid Services (CMS) announced that clinicians participating in the Quality Payment…
COVID-19 FDA Issues Revised Guidance on Adverse Event Reporting During a Pandemic Thomas Sullivan May 15, 2020 0 In response to rapidly changing conditions due to the COVID-19 pandemic, the US Food and Drug Administration (“FDA”) published a…